AP
FDA chief grilled on response to baby formula issue
The head of the Food and Drug Administration faced bipartisan fury from House lawmakers Wednesday over months of delays investigating problems at the nation's largest baby formula plant that prompted an ongoing shortage. FDA Commissioner Robert Califf laid out a series of setbacks in congressional testimony that slowed his agency's response, including a COVID-19 outbreak at the plant and a whistleblower complaint that didn't reach FDA leadership because it was apparently lost in the mail. Califf testified before a House subcommittee probing the shortage, which has snowballed into a major political controversy and forced the U.S. to begin airlifting products from Europe.
